Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07287371 · ClinicalTrials.gov registry record · Phase 4
Sucrosomial Vs Intravenous Iron for Preoperative Anemia
A Phase 4 study, sponsored by University of Rochester.
- Not yet
- Registry status
- Phase 4
- Development phase
- 75
- Enrollment target
NCT07287371 is a Phase 4 study that has not yet begun recruiting, run by University of Rochester. The registered enrollment target is 75 participants.
The verdict
NCT07287371, a Phase 4 study, has not yet begun recruiting, sponsored by University of Rochester.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 75 participants
- Enrollment target
Study Summary
50 patients with anemia scheduled for heart surgery or procedures will be randomized to receive either oral sucrosomial iron or standard-of-care intravenous iron before surgery to see if the oral iron is as effective as intravenous iron in increasing the red blood cell count.
Interventions
- DRUG Treatment with oral sucrosomial iron
- DRUG Treatment with intravenous iron
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-12-31 |
| Est. Completion | 2027-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07287371
The ClinicalTrials.gov registry entry for NCT07287371 describes a study currently listed as not yet recruiting, categorized as Phase 4. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Treatment with oral sucrosomial iron is the first listed.
NCT07287371 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07287371 about?
NCT07287371 is a clinical study titled "Sucrosomial Vs Intravenous Iron for Preoperative Anemia". 50 patients with anemia scheduled for heart surgery or procedures will be randomized to receive either oral sucrosomial iron or standard-of-care intravenous iron before surgery to see if the oral iron is as effective as intravenous iron in increasing the red blood cell count.
What is the current status of trial NCT07287371?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 75 participants. The study started on 2025-12-31. Estimated completion is 2027-06-30.
What interventions are being tested in trial NCT07287371?
The interventions under investigation include: Treatment with oral sucrosomial iron (DRUG), Treatment with intravenous iron (DRUG).
Who is sponsoring clinical trial NCT07287371?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.